Insta
Representative image. (Prasad Gori/Hindustan Times via Getty Images)
The Union government might approve new regulations to prevent pharma companies from selling different products under the same brand names, Mint has reported. This move will eliminate confusion over names of different medicines.
In a recent meeting called by the Union Health Ministry, it was concluded that brand and trade names used by pharma companies for their products neither follow the provisions of the Drugs and Cosmetics Act nor those of the Trade Marks Act, 1999. This provides these companies with considerable leeway to sell different products under the same brand names. Under the current scenario, customers might buy the wrong medicines which have the same name.
Attavar added that a change in law is required as the existing licences are issued under the generic name and companies are free to use any brand name. He added that a common registry of names and an online process would help in getting a search report easily. The government is also planning a databank for all medicines in order to prevent similar brand names for products which treat different ailments.
Also Read: Dilemma Of India’s Draft Pharma Policy
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest